Literature DB >> 30699358

PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis.

Caiyun G Li1, Cathal Mahon2, Nathaly M Sweeney1, Erik Verschueren3, Vivek Kantamani1, Dan Li1, Jan K Hennigs1, David P Marciano4, Isabel Diebold1, Ossama Abu-Halawa1, Matthew Elliott1, Silin Sa1, Feng Guo5, Lingli Wang1, Aiqin Cao1, Christophe Guignabert1, Julie Sollier6, Nils P Nickel1, Mark Kaschwich1, Karlene A Cimprich6, Marlene Rabinovitch7.   

Abstract

Using proteomic approaches, we uncovered a DNA damage response (DDR) function for peroxisome proliferator activated receptor γ (PPARγ) through its interaction with the DNA damage sensor MRE11-RAD50-NBS1 (MRN) and the E3 ubiquitin ligase UBR5. We show that PPARγ promotes ATM signaling and is essential for UBR5 activity targeting ATM interactor (ATMIN). PPARγ depletion increases ATMIN protein independent of transcription and suppresses DDR-induced ATM signaling. Blocking ATMIN in this context restores ATM activation and DNA repair. We illustrate the physiological relevance of PPARγ DDR functions by using pulmonary arterial hypertension (PAH) as a model that has impaired PPARγ signaling related to endothelial cell (EC) dysfunction and unresolved DNA damage. In pulmonary arterial ECs (PAECs) from PAH patients, we observed disrupted PPARγ-UBR5 interaction, heightened ATMIN expression, and DNA lesions. Blocking ATMIN in PAH PAEC restores ATM activation. Thus, impaired PPARγ DDR functions may explain the genomic instability and loss of endothelial homeostasis in PAH.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATM; DNA damage; MRN; PPARγ; endothelial cells; pulmonary hypertension; vascular biology

Mesh:

Substances:

Year:  2019        PMID: 30699358      PMCID: PMC6436616          DOI: 10.1016/j.celrep.2019.01.013

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  58 in total

1.  SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint.

Authors:  Parvin T Yazdi; Yi Wang; Song Zhao; Nimitt Patel; Eva Y-H P Lee; Jun Qin
Journal:  Genes Dev       Date:  2002-03-01       Impact factor: 11.361

2.  MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments.

Authors:  Meena Choi; Ching-Yun Chang; Timothy Clough; Daniel Broudy; Trevor Killeen; Brendan MacLean; Olga Vitek
Journal:  Bioinformatics       Date:  2014-05-02       Impact factor: 6.937

3.  Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival.

Authors:  Tero-Pekka Alastalo; Molong Li; Vinicio de Jesus Perez; David Pham; Hirofumi Sawada; Jordon K Wang; Minna Koskenvuo; Lingli Wang; Bruce A Freeman; Howard Y Chang; Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2011-08-08       Impact factor: 14.808

Review 4.  PPARgamma and the pathobiology of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  Skp2 E3 ligase integrates ATM activation and homologous recombination repair by ubiquitinating NBS1.

Authors:  Juan Wu; Xian Zhang; Ling Zhang; Ching-Yuan Wu; Abdol Hossein Rezaeian; Chia-Hsin Chan; Ju-Mei Li; Jing Wang; Yuan Gao; Fei Han; Yun Seong Jeong; Xiandao Yuan; Kum Kum Khanna; Jianping Jin; Yi-Xin Zeng; Hui-Kuan Lin
Journal:  Mol Cell       Date:  2012-03-29       Impact factor: 17.970

Review 6.  Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications.

Authors:  Sophie E Polo; Stephen P Jackson
Journal:  Genes Dev       Date:  2011-03-01       Impact factor: 11.361

7.  PPARγ is an E3 ligase that induces the degradation of NFκB/p65.

Authors:  Yongzhong Hou; France Moreau; Kris Chadee
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

8.  Loss of PPARγ in endothelial cells leads to impaired angiogenesis.

Authors:  Sanna Vattulainen-Collanus; Oyediran Akinrinade; Molong Li; Minna Koskenvuo; Caiyun Grace Li; Shailaja P Rao; Vinicio de Jesus Perez; Ke Yuan; Hirofumi Sawada; Juha W Koskenvuo; Cristina Alvira; Marlene Rabinovitch; Tero-Pekka Alastalo
Journal:  J Cell Sci       Date:  2016-01-07       Impact factor: 5.285

9.  Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex.

Authors:  Ji-Hoon Lee; Tanya T Paull
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

10.  ATMIN is a transcriptional regulator of both lung morphogenesis and ciliogenesis.

Authors:  Paraskevi Goggolidou; Jonathan L Stevens; Francesco Agueci; Jennifer Keynton; Gabrielle Wheway; Daniel T Grimes; Saloni H Patel; Helen Hilton; Stine K Morthorst; Antonella DiPaolo; Debbie J Williams; Jeremy Sanderson; Svetlana V Khoronenkova; Nicola Powles-Glover; Alexander Ermakov; Chris T Esapa; Rosario Romero; Grigory L Dianov; James Briscoe; Colin A Johnson; Lotte B Pedersen; Dominic P Norris
Journal:  Development       Date:  2014-10       Impact factor: 6.868

View more
  23 in total

Review 1.  Activation of the Metabolic Master Regulator PPARγ: A Potential PIOneering Therapy for Pulmonary Arterial Hypertension.

Authors:  Georg Hansmann; Laurent Calvier; Michael G Risbano; Stephen Y Chan
Journal:  Am J Respir Cell Mol Biol       Date:  2020-02       Impact factor: 6.914

2.  A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer.

Authors:  Malene Blond Ipsen; Ea Marie Givskov Sørensen; Emil Aagaard Thomsen; Simone Weiss; Jakob Haldrup; Anders Dalby; Johan Palmfeldt; Peter Bross; Martin Rasmussen; Jacob Fredsøe; Søren Klingenberg; Mads R Jochumsen; Kirsten Bouchelouche; Benedicte Parm Ulhøi; Michael Borre; Jacob Giehm Mikkelsen; Karina Dalsgaard Sørensen
Journal:  Oncogene       Date:  2022-08-06       Impact factor: 8.756

3.  ATMIN enhances invasion by altering PARP1 in MSS colorectal cancer.

Authors:  Yue-Ju Li; Cheng-Ning Yang; Mark Yen-Ping Kuo; Wei-Ting Lai; Tai-Sheng Wu; Been-Ren Lin
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

4.  Frataxin deficiency promotes endothelial senescence in pulmonary hypertension.

Authors:  Miranda K Culley; Jingsi Zhao; Yi Yin Tai; Ying Tang; Dror Perk; Vinny Negi; Qiujun Yu; Chen-Shan C Woodcock; Adam Handen; Gil Speyer; Seungchan Kim; Yen-Chun Lai; Taijyu Satoh; Annie Mm Watson; Yassmin Al Aaraj; John Sembrat; Mauricio Rojas; Dmitry Goncharov; Elena A Goncharova; Omar F Khan; Daniel G Anderson; James E Dahlman; Aditi U Gurkar; Robert Lafyatis; Ahmed U Fayyaz; Margaret M Redfield; Mark T Gladwin; Marlene Rabinovitch; Mingxia Gu; Thomas Bertero; Stephen Y Chan
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 14.808

5.  PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.

Authors:  Jan K Hennigs; Aiqin Cao; Caiyun G Li; Minyi Shi; Julia Mienert; Kazuya Miyagawa; Jakob Körbelin; David P Marciano; Pin-I Chen; Matthew Roughley; Matthew V Elliott; Rebecca L Harper; Matthew A Bill; James Chappell; Jan-Renier Moonen; Isabel Diebold; Lingli Wang; Michael P Snyder; Marlene Rabinovitch
Journal:  Circ Res       Date:  2020-12-16       Impact factor: 17.367

Review 6.  Endothelial cells in the pathogenesis of pulmonary arterial hypertension.

Authors:  Colin E Evans; Nicholas D Cober; Zhiyu Dai; Duncan J Stewart; You-Yang Zhao
Journal:  Eur Respir J       Date:  2021-09-02       Impact factor: 33.795

7.  ATMIN Suppresses Metastasis by Altering the WNT-Signaling Pathway via PARP1 in MSI-High Colorectal Cancer.

Authors:  Yue-Ju Li; Cheng-Ning Yang; Mark Yen-Ping Kuo; Wei-Ting Lai; Tai-Sheng Wu; Been-Ren Lin
Journal:  Ann Surg Oncol       Date:  2021-06-19       Impact factor: 5.344

Review 8.  PPAR control of metabolism and cardiovascular functions.

Authors:  David Montaigne; Laura Butruille; Bart Staels
Journal:  Nat Rev Cardiol       Date:  2021-06-14       Impact factor: 32.419

9.  PPARγ Mediates the Anti-Epithelial-Mesenchymal Transition Effects of FGF1ΔHBS in Chronic Kidney Diseases via Inhibition of TGF-β1/SMAD3 Signaling.

Authors:  Dezhong Wang; Tianyang Zhao; Yushuo Zhao; Yuan Yin; Yuli Huang; Zizhao Cheng; Beibei Wang; Sidan Liu; Minling Pan; Difei Sun; Zengshou Wang; Guanghui Zhu
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

10.  ILF3 Is a Negative Transcriptional Regulator of Innate Immune Responses and Myeloid Dendritic Cell Maturation.

Authors:  Rodolfo Nazitto; Lynn M Amon; Fred D Mast; John D Aitchison; Alan Aderem; Jarrod S Johnson; Alan H Diercks
Journal:  J Immunol       Date:  2021-05-24       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.